DAVID E. I. PYOTT - 18 Feb 2026 Form 3 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
3
Filing time
20 Feb 2026, 16:35:33 UTC
Previous filing
09 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PYOTT DAVID E I Director C/O TARSUS PHARMACEUTICALS, 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE /s/ Scott Sieckert, Attorney-in-Fact 20 Feb 2026 0001051578

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TARS Common Stock 7,991 18 Feb 2026 By the David E.I. Pyott Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TARS Stock Option (right to buy) 18 Feb 2026 Common Stock 7,000 $12.97 Direct F1
holding TARS Stock Option (right to buy) 18 Feb 2026 Common Stock 2,500 $18.27 Direct F2
holding TARS Stock Option (right to buy) 18 Feb 2026 Common Stock 2,500 $32.76 Direct F3
holding TARS Stock Option (right to buy) 18 Feb 2026 Common Stock 2,128 $49.97 Direct F4
holding TARS Restricted Stock Units 18 Feb 2026 Common Stock 1,383 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan (the "Plan"). The option shares vested and became exercisable on April 24, 2023.
F2 Option granted under the Plan. The option shares vested and became exercisable on August 1, 2024.
F3 Option granted under the Plan. The option shares vested and became exercisable on April 24, 2025.
F4 Option granted under the Plan. The option shares vest and become exercisable on April 24, 2026, subject to the Reporting Person's continuous service.
F5 Restricted Stock Units ("RSUs") granted under the Plan. The RSUs vest on April 24, 2026, subject to the Reporting Person's continuous service.

Remarks:

Exhibit 24 - Power of Attorney